Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2015 May 27;120:148–154. doi: 10.1016/j.prostaglandins.2015.04.011

Figure 2.

Figure 2

Effect of HFD and treatments with t-AUCB and glibenclamide on body weight (A), and fasting glycemia (B). Results are mean±SE, n=11-27/group. *p < 0.05 vs. control, #p < 0.05 vs. HFD, †p < 0.05 vs. HFD+t-AUCB.